Pain Therapeutics is providing opiates for the masses. The development-stage company is working on abuse-resistant painkillers, including Remoxy, a version of the frequently abused Oxycontin. Pain Therapeutics is developing Remoxy and other painkiller candidates in partnership with Pfizer, which holds all of the commercialization rights to the drugs. In addition to its chronic pain candidates, Pain Therapeutics has development programs in oncology and hematology underway. Because many of its drug candidates already contain FDA-approved components, the firm hopes for a faster approval process on its lead candidates.